Clinical Trial for Idiopathic Hip Pain Using Peripheral Nerve Stimulation

Inclusion Criteria: * Capable of giving informed consent; * Capable and willing to follow all study related procedures; * Women and men \>18 years of age; * Diagnosis of hip pain; * Baseline VAS score of \>5; * \>50% temporary relief from temporary nerve diagnostic evaluation; * No evidence of anatomic abnormalities that could jeopardize device placement; * Able to operate programmer, recharger, study assessments and provide accurate responses; * Appropriate candidate for the implant procedure. Exclusion Criteria: * An active implantable electronic device regardless of whether stimulation is ON or OFF; * Pregnant or plan to become pregnant during study; * Less than 1-year post-partum and/or are breast-feeding; * Symptoms existing for less than 6 months; * Multiple complaints that will not be amenable to study; * Current diagnosis of a Neurological disease; * Daily opioid usage exceeding CDC recommendations; * Dependency on utilizing wearable or transcutaneous monitoring device (hearing aids, continuous glucose monitors, etc.); * Conditions requiring recurring MRI evaluation or diathermy procedures; * Uncontrolled diabetes (HbA1C \> 8.5); * Known or suspected substance abuse within the last 2-years; * Uncontrolled major depression or uncontrolled psychiatric disorders; * Worker's compensation claimants; * History of adverse reaction to local anesthetic drugs; * History of coagulopathy or bleeding disorder; * Anatomical restrictions such that device placement is not possible; * Chronic or acute conditions that could interfere with the interpretations of the outcome assessment for pain and bodily function; * Have a life expectancy of less than 1-year; * Neurogenic or vascular claudication; * Inability to achieve appropriate positioning and inability to understand informed consent and protocol; * Deemed unsuitable for enrollment by investigator based on history or physical examination.